| Description |
calcium dependent secretion activator |
KIAA1549 |
| Image |
|
No pdb structure |
| GO Annotations |
Cellular Component |
|
|
| Molecular Function |
|
|
| Biological Process |
|
|
| Pathways |
|
|
| Drugs |
|
|
| Diseases |
|
|
| GWAS |
- Autism spectrum disorder ( 30804558)
- Breast size ( 22747683 27182965)
- Cognitive decline rate in late mild cognitive impairment ( 26252872)
- Economic and political preferences (environmentalism) ( 22566634)
- Hand grip strength ( 29691431)
- Lung function (FEV1/FVC) ( 30061609)
- Metabolite levels (X-11787) ( 23934736)
- Obsessive-compulsive symptoms ( 26859814)
- Optic disc size ( 31809533)
- Pre-treatment viral load in HIV-1 infection ( 31219150)
- QT interval (sulfonylurea treatment interaction) ( 27958378)
- Risk-taking tendency (4-domain principal component model) ( 30643258)
- Thiopurine-induced leukopenia in inflammatory bowel disease ( 29923122)
- Trunk fat mass ( 28552196)
|
|
| Interacting Genes |
15 interacting genes:
C17orf67
DMD
DNAJC5
DRD2
FAM161A
FAM9B
KIAA1549
LUC7L2
PIP5K1A
SDCBP
SHFL
TCL1A
TTLL10
ZNF572
ZNF688
|
10 interacting genes:
CADPS
CDC73
DST
GNE
ITSN2
LGALS4
MBD5
MYO5B
SOD2
ZBTB16
|
| Entrez ID |
8618 |
57670 |
| HPRD ID |
05236 |
13873 |
| Ensembl ID |
ENSG00000163618
|
ENSG00000122778
|
| Uniprot IDs |
F1T0E5
Q9ULU8
|
Q9HCM3
|
| PDB IDs |
1WI1
|
|
| Enriched GO Terms of Interacting Partners? |
|
|
| Tagcloud ? |
|
|
| Tagcloud (Difference) ? |
|
|
| Tagcloud (Intersection) ? |
|